ATMP Facilities: Adapting to a Multimodal Future

What is driving more ATMP manufacturers to develop multimodal facilities, evolve their equipment and push for more modern manufacturing facilities? Peter Walters, CRB’s Director of Advanced Therapies, and Matthew Hewitt, Executive Director, Scientific Solutions Cell & Gene Therapy at Charles River Laboratories, share more in ISPE’s Pharmaceutical Engineering®: http://ow.ly/IIuc50JBQbJ

View additional multimedia and more ESG storytelling from CRB on 3blmedia.com